TYRA Stock Analysis: Buy, Sell, or Hold?
TYRA - Tyra Biosciences, Inc. Common Stock
$30.82
-1.52 (-4.70%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 25, 2026
Get Alerted When TYRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: TYRA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: TYRA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: TYRA is currently trading at $30.82, which is considered extended relative to its 30-day fair value range of $26.59 to $30.72.
Technical Outlook: Technically, TYRA is in a strong uptrend. Immediate support is located at $27.40, while resistance sits at $32.44. Short-term momentum is weak, with the stock down 4.7% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $37.88 (+17.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TYRA is in a strong uptrend. Immediate support is located at $27.40, while resistance sits at $32.44. Short-term momentum is weak, with the stock down 4.7% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $37.88 (+17.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$26.59 -
$30.72
Company Quality Score
63/100
(BUY)
Options IV Signal
31th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
48.8%
Protect Your Profits
Holding TYRA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Options fairly priced (IV 31th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.7%)
- BULLISH: Trading below Wall St target ($37.88)
Fair Price Analysis
30-Day Fair Range
$26.59 -
$30.72
Current vs Fair Value
EXTENDED
Expected Move (7 Days)
±$3.71
(12.0%)
Support & Resistance Levels
Support Level
$27.40
Resistance Level
$32.44
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-14.60
Wall Street Target
$37.88
(+17.1%)
Last updated: January 31, 2026 1:18 PM ET
Data refreshes hourly during market hours. Next update: 2:18 PM
Data refreshes hourly during market hours. Next update: 2:18 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TYRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$22 | 60 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$141 | 59 HOLD |
Advanced TYRA Option Strategies
Professional options setups generated by AI based on today's TYRA price and gamma walls.
